1. Home
  2. PESI vs CMPX Comparison

PESI vs CMPX Comparison

Compare PESI & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Perma-Fix Environmental Services Inc.

PESI

Perma-Fix Environmental Services Inc.

N/A

Current Price

$12.80

Market Cap

243.9M

Sector

Industrials

ML Signal

N/A

Logo Compass Therapeutics Inc.

CMPX

Compass Therapeutics Inc.

N/A

Current Price

$5.20

Market Cap

926.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PESI
CMPX
Founded
1990
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Environmental Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
243.9M
926.7M
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
PESI
CMPX
Price
$12.80
$5.20
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
$14.43
AVG Volume (30 Days)
116.6K
1.8M
Earning Date
01-01-0001
05-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$60,030,000.00
N/A
Revenue This Year
$9.91
N/A
Revenue Next Year
$62.48
$830.89
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.25
$1.33
52 Week High
$16.50
$6.88

Technical Indicators

Market Signals
Indicator
PESI
CMPX
Relative Strength Index (RSI) 37.73 33.42
Support Level $12.40 $4.78
Resistance Level $14.80 $5.86
Average True Range (ATR) 0.80 0.32
MACD -0.10 -0.07
Stochastic Oscillator 15.00 1.47

Price Performance

Historical Comparison
PESI
CMPX

About PESI Perma-Fix Environmental Services Inc.

Perma-Fix Environmental Services Inc is a provider of both nuclear services and the management of nuclear and mixed waste. The company operates through two segments: The treatment segment offers nuclear, low-level radioactive, Mixed, hazardous and non-hazardous waste treatment, processing and disposal services, and the Services segment which generates the majority of the revenue, provides on-site waste management services to commercial and government customers, technology-based services, construction, logistics, and transportation services among others.

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.

Share on Social Networks: